House Energy and Commerce Committee - Hearing
Subject: FDA Generic Drug/Biosimilar User Fee Programs
Witnesses: Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research
Location: 2123 Rayburn House Office Building
Time: 10:00 am EDT, Date: Thursday, March 2nd, 2017
You must be a Subscriber to read the full transcript.
Subscribing has benefits:
- Unlimited access to our transcripts database of over 220,000 transcripts.
- First access to current transcripted events, even while they are being transcribed.
- Direct email alerts detailing our coverage schedule so you can plan ahead.